Literature DB >> 18224361

Methicillin-resistant versus methicillin-sensitive Staphylococcus aureus infective endocarditis.

E E Hill1, W E Peetermans, S Vanderschueren, P Claus, M-C Herregods, P Herijgers.   

Abstract

The incidence of methicillin-resistant Staphylococcus aureus (MRSA) infective endocarditis (IE) is increasing. This study compared clinical characteristics and mortality in patients with methicillin-sensitive S. aureus (MSSA) IE versus MRSA IE, based on a prospectively collected series of 72 consecutive patients with definite S. aureus IE according to the modified Duke criteria between June 2000 and December 2006. Sixteen of 72 IE patients (22%) were caused by MRSA. Nosocomial origin, surgical site infection, surgery in the previous 6 months, the presence of a catheter and persistent bacteremia were significantly associated with MRSA. MSSA patients had significantly more unknown origin of bacteremia and experienced a significantly higher rate of major embolism than MRSA patients. MSSA patients underwent more frequently combined surgical and antimicrobial therapy, and MRSA patients were treated more frequently with antimicrobial therapy due to a contraindication to surgery. The 6-month mortality was higher in patients with MRSA than MSSA. In the MSSA group treated with antimicrobial therapy without an indication to surgery, all patients survived, and in the combined surgical and antimicrobial group 29% died. The mortality in MRSA patients was lowest if combined surgical and antimicrobial therapy was performed. Both in MSSA and MRSA patients with antimicrobial therapy due to a contraindication to surgery, the mortality was extremely high. These data suggest that in S. aureus IE patients with a nosocomial origin, the presence of a catheter or recent surgery, initial therapy should include antimicrobial agents active against MRSA. Antimicrobial therapy alone with close monitoring of the therapeutic effect and signs of complicated course is an acceptable approach in selected patients with MSSA IE. Denial of surgery because of local or general factors in patients that meet criteria for surgical intervention in acute IE is prognostically ominous.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18224361     DOI: 10.1007/s10096-007-0458-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  21 in total

Review 1.  Guidelines for the management of intravascular catheter-related infections.

Authors:  L A Mermel; B M Farr; R J Sherertz; I I Raad; N O'Grady; J S Harris; D E Craven
Journal:  Clin Infect Dis       Date:  2001-04-03       Impact factor: 9.079

2.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Authors:  J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey
Journal:  Clin Infect Dis       Date:  2000-04-03       Impact factor: 9.079

3.  Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology.

Authors:  Dieter Horstkotte; Ferenc Follath; Erno Gutschik; Maria Lengyel; Ali Oto; Alain Pavie; Jordi Soler-Soler; Gaetano Thiene; Alexander von Graevenitz; Silvia G Priori; Maria Angeles Alonso Garcia; Jean-Jacques Blanc; Andrzej Budaj; Martin Cowie; Veronica Dean; Jaap Deckers; Enrique Fernández Burgos; John Lekakis; Bertil Lindahl; Gianfranco Mazzotta; João Morais; Ali Oto; Otto A Smiseth; John Lekakis; Alec Vahanian; François Delahaye; Alexander Parkhomenko; Gerasimos Filipatos; Jan Aldershvile; Panos Vardas
Journal:  Eur Heart J       Date:  2004-02       Impact factor: 29.983

4.  Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database.

Authors:  Christopher H Cabell; Elias Abrutyn; Vance G Fowler; Bruno Hoen; Jose M Miro; G Ralph Corey; Lars Olaison; Paul Pappas; Kevin J Anstrom; Judith A Stafford; Susannah Eykyn; Gilbert Habib; Carlos A Mestres; Andrew Wang
Journal:  Am Heart J       Date:  2005-11       Impact factor: 4.749

5.  Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America.

Authors:  Larry M Baddour; Walter R Wilson; Arnold S Bayer; Vance G Fowler; Ann F Bolger; Matthew E Levison; Patricia Ferrieri; Michael A Gerber; Lloyd Y Tani; Michael H Gewitz; David C Tong; James M Steckelberg; Robert S Baltimore; Stanford T Shulman; Jane C Burns; Donald A Falace; Jane W Newburger; Thomas J Pallasch; Masato Takahashi; Kathryn A Taubert
Journal:  Circulation       Date:  2005-06-14       Impact factor: 29.690

6.  Staphylococcus aureus endocarditis: a consequence of medical progress.

Authors:  Vance G Fowler; Jose M Miro; Bruno Hoen; Christopher H Cabell; Elias Abrutyn; Ethan Rubinstein; G Ralph Corey; Denis Spelman; Suzanne F Bradley; Bruno Barsic; Paul A Pappas; Kevin J Anstrom; Dannah Wray; Claudio Q Fortes; Ignasi Anguera; Eugene Athan; Philip Jones; Jan T M van der Meer; Tom S J Elliott; Donald P Levine; Arnold S Bayer
Journal:  JAMA       Date:  2005-06-22       Impact factor: 56.272

7.  A comparison of hospital and community-acquired infective endocarditis.

Authors:  S C Chen; D E Dwyer; T C Sorrell
Journal:  Am J Cardiol       Date:  1992-12-01       Impact factor: 2.778

Review 8.  Thrombo-embolic complications in bacteraemic infections.

Authors:  V Valtonen; A Kuikka; J Syrjänen
Journal:  Eur Heart J       Date:  1993-12       Impact factor: 29.983

Review 9.  Infection as a risk factor for cerebral infarction.

Authors:  J Syrjänen
Journal:  Eur Heart J       Date:  1993-12       Impact factor: 29.983

10.  Introduction of the mec element (methicillin resistance) into Staphylococcus aureus alters in vitro functional activities of fibrinogen and fibronectin adhesins.

Authors:  P E Vaudaux; V Monzillo; P Francois; D P Lew; T J Foster; B Berger-Bächi
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

View more
  11 in total

1.  [Septic arthritis as an initial manifestation of a bacterial endocarditis].

Authors:  M Gothner; T Ramczykowski; A Ewers; T Kälicke; S Shah; T A Schildhauer; J Swol
Journal:  Unfallchirurg       Date:  2013-05       Impact factor: 1.000

2.  Value of PCR in surgically treated patients with staphylococcal infective endocarditis: a 4-year retrospective study.

Authors:  B Zaloudíková; E Němcová; J Pol; Z Sorm; S Wurmová; K Novotná; M Vaněrková; V Holá; F Růžička; L Dušek; P Němec; T Freiberger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-02       Impact factor: 3.267

3.  Screening cardiac surgery patients for MRSA: an economic computer model.

Authors:  Bruce Y Lee; Ann E Wiringa; Rachel R Bailey; Vishal Goyal; G Jonathan Lewis; Becky Y K Tsui; Kenneth J Smith; Robert R Muder
Journal:  Am J Manag Care       Date:  2010-07-01       Impact factor: 2.229

4.  Comparison of antimicrobial agents as therapy for experimental endocarditis: caused by methicillin-resistant Staphylococcus aureus.

Authors:  Mustafa Sacar; Suzan Sacar; Nural Cevahir; Gokhan Onem; Zafer Teke; Ali Asan; Huseyin Turgut; Fahri Adali; Ilknur Kaleli; Ibrahim Susam; Yalin Tolga Yaylali; Ahmet Baltalarli
Journal:  Tex Heart Inst J       Date:  2010

5.  Improved Neurological Outcome in a Patient With Complicated Mitral Valve Endocarditis Treated With Daptomycin-Rifampin Regimen.

Authors:  Syed S Fatmi; Rafaela Basso; Ravitej Goteti
Journal:  Cureus       Date:  2022-03-28

6.  Changing Italian nosocomial-community trends and heteroresistance in Staphylococcus aureus from bacteremia and endocarditis.

Authors:  F Campanile; D Bongiorno; M Falcone; F Vailati; M B Pasticci; M Perez; A Raglio; F Rumpianesi; C Scuderi; F Suter; M Venditti; C Venturelli; V Ravasio; M Codeluppi; S Stefani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-07       Impact factor: 3.267

7.  Daptomycin for the Treatment of Infective Endocarditis: Results from European Cubicin(®) Outcomes Registry and Experience (EU-CORE).

Authors:  Achyut Guleri; Riccardo Utili; Pascal Dohmen; Nicola Petrosillo; Cornelia Piper; Rashidkhan Pathan; Kamal Hamed
Journal:  Infect Dis Ther       Date:  2015-07-14

Review 8.  Fatal endocarditis with methicilin-sensible Staphylococcus aureus and major complications: rhabdomyolysis, pericarditis, and intracerebral hematoma: A case report and review of the literature.

Authors:  Anca Meda Georgescu; Leonard Azamfirei; Krisztina Szalman; Edit Szekely
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

9.  Burden of Invasive Staphylococcus aureus Infections in Hospitalized Infants.

Authors:  Jessica E Ericson; Victor O Popoola; P Brian Smith; Daniel K Benjamin; Vance G Fowler; Daniel K Benjamin; Reese H Clark; Aaron M Milstone
Journal:  JAMA Pediatr       Date:  2015-12       Impact factor: 26.796

10.  Staphylococcus aureus CC30 Lineage and Absence of sed,j,r-Harboring Plasmid Predict Embolism in Infective Endocarditis.

Authors:  Jean-Philippe Rasigade; Amélie Leclère; François Alla; Adrien Tessier; Michèle Bes; Catherine Lechiche; Véronique Vernet-Garnier; Cédric Laouénan; François Vandenesch; Catherine Leport
Journal:  Front Cell Infect Microbiol       Date:  2018-06-08       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.